12935 Results

People

  1. Weigelt
    Weigelt
  2. Reis-Filho
    Reis-Filho
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Berger
    Berger
  6. Deasy
    Deasy
  7. Solit
    Solit
  8. Lewis
    Lewis
  9. Schultz
    Schultz
  10. De Stanchina
    De Stanchina

Groups

  1. Sloan Kettering Institute Postdocs (12935)
  2. GSK Faculty (6209)
  3. Department of Medicine (4655)
  4. Sloan Kettering Institute Faculty (3489)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)
  7. Department of Pathology and Laboratory Medicine (2500)
  8. Center for Hematologic Malignancies (2323)
  9. Epidemiology and Biostatistics (1996)
  10. Human Oncology and Pathogenesis Program (1984)
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3611)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12935)
  2. GSK Faculty (6209)
  3. Department of Medicine (4655)
  4. Sloan Kettering Institute Faculty (3489)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (393)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12935)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor immune microenvironment determinants of response to Lenvatinib and aPD-1 blockade in clear cell renal cell carcinoma
    Meeting Abstract

    Vuong, L.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Circulating leptin and immune-related transcriptomic patterns in clear cell renal cell carcinoma
    Meeting Abstract

    Posada Calderon, L.; Olsson, L.; Kuo, F.; Dawidek, M.; Barbakoff, D.; Ganz, M.; Jiang, H.; Coleman, J. A.; Russo, P.; Furberg, H.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Correction of small bias for clinically relevant CpG sites interrogated by the updated EPICv2/900K methylation array
    Meeting Abstract

    Aldyab, M.; Upadhyayula, N.; Borsu, L.; Nafa, K.; Villafania, L.; Zaidinski, M.; Mullhaney, K.; Bale, T.; Arcila, M.; Ladanyi, M.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Critical roles of type I interferon receptor signaling in myeloid and T cells for virus-induced antitumor responses
    Meeting Abstract

    Baseer Tariq, S.; Wang, Y.; Wang, W.; Salla, B.; Wang, Y.; Liu, S.; Yang, N.; Li, M.; Deng, L.
    Journal of Investigative Dermatology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade
    Meeting Abstract

    Ricciuti, B.; Gariazzo, E.; Gorria, T.; Thummalapalli, R.; Citarella, F.; Gandhi, M. M.; Elkrief, A.; Pecci, F.; Alessi, J. V. M.; Di Federico, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patient factors associated with chemotherapy modifications: Results from the Optimal Breast Cancer Chemotherapy Dosing (OBCD) study
    Meeting Abstract

    Kantor, E.; Bhimani, J.; Gallagher, G. B.; Blinder, V. S.; Burganowski, R. P.; Griggs, J. J.; Kolevska, T.; Kroenke, C.; Laurent, C.; Liu, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patient characteristics associated with primary prophylactic granulocyte colony-stimulating factor (G-CSF) use among women treated for early-stage breast cancer
    Meeting Abstract

    Gallagher, G. B.; O'Connell, K.; Bhimani, J.; Blinder, V. S.; Burganowski, R. P.; Griggs, J. J.; Kolevska, T.; Kroenke, C.; Laurent, C.; Liu, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • CCNE1 amplification as marker of poor prognosis and novel therapeutic target in advanced breast cancer
    Meeting Abstract

    Marra, A.; Selenica, P.; Zhu, Y.; Safonov, A.; Razavi, P.; Roulston, A.; Koehler, M.; Curigliano, G.; Ross, D. S.; Weigelt, B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • TTF-1 negativity as a biomarker of outcomes to immunotherapy, chemoimmunotherapy, and KRAS G12C inhibitors in lung adenocarcinoma
    Meeting Abstract

    Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Shaverdian, N.; Ricciuti, B.; Alessi, J. V. M.; De Giglio, A.; Pecci, F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Shareable artificial intelligence to extract cancer outcomes from electronic health records
    Meeting Abstract

    Kehl, K. L.; Jee, J.; Pichotta, K.; Trukhanov, P.; Fong, C.; Waters, M.; Nichols, C.; Cerami, E.; Schrag, D.; Schultz, N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save